Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.
暂无分享,去创建一个
Rahman Azari | Richard L Kravitz | Ronald M Epstein | Peter Franks | R. Epstein | R. Kravitz | C. Franz | M. Feldman | P. Franks | R. Azari | L. Hinton | M. Wilkes | Mitchell D Feldman | Ladson Hinton | Carol E Franz | Michael S Wilkes
[1] Chad Boult,et al. Caring for Older Americans: The Future of Geriatric Medicine , 2005, Journal of the American Geriatrics Society.
[2] D. Gunnell,et al. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review , 2005, BMJ : British Medical Journal.
[3] Ernst R Berndt,et al. Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines for Depression , 2004, Medical care.
[4] D. Kupfer,et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. , 2004, The American journal of psychiatry.
[5] Gretchen Guiton,et al. Communication Skills in Standardized-Patient Assessment of Final-Year Medical Students: A Psychometric Study , 2004, Advances in health sciences education : theory and practice.
[6] D. Blumenthal,et al. Physicians report on patient encounters involving direct-to-consumer advertising. , 2004, Health affairs.
[7] F. Dijk,et al. Dutch practice guidelines for managing adjustment disorders in occupational and primary health care. , 2003 .
[8] G. Roberts,et al. Explanations for Improvement in Both Experimental and Control Groups , 2003, Western journal of nursing research.
[9] R. Kravitz,et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] R. Kravitz,et al. Direct observation of requests for clinical services in office practice: what do patients want and do they get it? , 2003, Archives of internal medicine.
[11] D. Blumenthal,et al. Consumers' reports on the health effects of direct-to-consumer drug advertising. , 2003, Health affairs.
[12] M. Rosenthal,et al. Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers. , 2003, JAMA.
[13] B. Raingruber. Client and provider perspectives regarding the stigma of and nonstigmatizing interventions for depression. , 2002, Archives of psychiatric nursing.
[14] J. Luck,et al. Using standardised patients to measure physicians' practice: validation study using audio recordings , 2002, BMJ : British Medical Journal.
[15] G. Simon. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. , 2002, General hospital psychiatry.
[16] S. van der Linden,et al. Doctor-patient interaction: standardized patients' reflections from inside the rheumatological office. , 2002, The Journal of rheumatology.
[17] R. Kravitz,et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey , 2002, BMJ : British Medical Journal.
[18] R. Kravitz,et al. Request Fulfillment in Office Practice: Antecedents and Relationship to Outcomes , 2002, Medical care.
[19] N. Duan,et al. Two-year effects of quality improvement programs on medication management for depression. , 2001, Archives of general psychiatry.
[20] B. Leff,et al. The future history of home care and physician house calls in the United States. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[21] M. Hegel,et al. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. , 2001, The Journal of family practice.
[22] J. Ferguson. SSRI Antidepressant Medications: Adverse Effects and Tolerability. , 2001, Primary care companion to the Journal of clinical psychiatry.
[23] P. Glassman,et al. Using standardized patients to measure quality: evidence from the literature and a prospective study. , 2000, The Joint Commission journal on quality improvement.
[24] J W Peabody,et al. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. , 2000, JAMA.
[25] R. Kravitz,et al. Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals. , 2000, The Journal of family practice.
[26] M S Wilkes,et al. Direct-to-consumer prescription drug advertising: trends, impact, and implications. , 2000, Health affairs.
[27] C. Sherbourne,et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. , 2000, JAMA.
[28] G. Wolford,et al. How physician communication influences recognition of depression in primary care. , 1999, The Journal of family practice.
[29] R. Kravitz,et al. Direct-to-consumer prescription drug advertising and the public , 1999, Journal of General Internal Medicine.
[30] K. Wells,et al. Quality of care for primary care patients with depression in managed care. , 1999, Archives of family medicine.
[31] M S Wilkes,et al. Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. , 1999, The Journal of family practice.
[32] M. Hollon. Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.
[33] A. F. Holmer,et al. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. , 1999, JAMA.
[34] S. Roose,et al. SSRI safety in overdose. , 1998, The Journal of clinical psychiatry.
[35] A. Agresti,et al. Approximate is Better than “Exact” for Interval Estimation of Binomial Proportions , 1998 .
[36] G. Taler. House Calls for the 21st Century , 1998, Journal of the American Geriatrics Society.
[37] G. Meyer,et al. House calls to the elderly--a vanishing practice among physicians. , 1997, The New England journal of medicine.
[38] N. Powe,et al. Identification of patient attitudes and preferences regarding treatment of depression , 1997, Journal of General Internal Medicine.
[39] S. K. Guthrie,et al. Depression in Primary Care: Review of AHCPR Guidelines , 1997, The Annals of pharmacotherapy.
[40] J. Rethans,et al. The use of standardized patients in research in general practice. , 1997, Family practice.
[41] J. Whyte. Direct consumer advertising of prescription drugs. , 1993, JAMA.
[42] M. Abrahamowicz,et al. First‐visit bias in the measurement of clinical competence with standardized patients , 1992, Academic medicine : journal of the Association of American Medical Colleges.
[43] Sharon A Levine,et al. Home care. , 2003, JAMA.
[44] Richard L Kravitz,et al. Characterizing patient requests and physician responses in office practice. , 2002, Health services research.
[45] Rnold,et al. PROMOTION OF PRESCRIPTION DRUGS TO CONSUMERS , 2002 .
[46] S. R. Searle,et al. Generalized, Linear, and Mixed Models , 2005 .
[47] J. Deakin,et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. , 2000, Journal of psychopharmacology.
[48] D. Antonuccio. Chapter 2 – Major Depressive Episode , 2000 .
[49] J. L. Taylor,et al. Rural-urban differences in stigma and the use of care for depressive disorders. , 1993, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.
[50] P. Kramer. Listening to Prozac , 1993 .